Newsroom

November 12, 2019
GAAP net sales of $1.0 billion , an increase of 10% year-over-year; non-GAAP pro forma organic net sales increased 5% year-over-year   Net loss of $906 million , including a non-cash goodwill impairment charge of $939 million ; non-GAAP adjusted net income of $19 million , a decline of 10%
November 4, 2019
Funds raised will provide diabetes medication for companion animals PORTLAND, Maine --(BUSINESS WIRE)--Nov. 4, 2019-- In recognition of National Diabetes Month , Covetrus ®  (NASDAQ: CVET), a global leader in animal-health technology and services, will donate $1 to The Pet Fund ® for every order
October 22, 2019
Benjamin Shaw steps down as CEO and president and will serve as a strategic advisor to the board of Covetrus . Board chair Wolin to assume role as acting CEO and president, lead independent director Laskawy to serve as board chair. PORTLAND, Maine --(BUSINESS WIRE)--Oct.
October 1, 2019
  VSG selects Covetrus as a Preferred Partner for prescription management and specialty pharmacy     PORTLAND, Maine --(BUSINESS WIRE)--Oct. 1, 2019-- Covetrus  (NASDAQ: CVET), a global leader in animal-health technology and services, announced a newly expanded strategic partnership with Veterinary
September 23, 2019
  Veteran HR and operations executive with experience supporting global organizations through transformation joins Covetrus executive leadership team     PORTLAND, Maine --(BUSINESS WIRE)--Sep. 23, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today
September 4, 2019
Independent Director Benjamin Wolin Assumes Board Chair Role PORTLAND, Maine --(BUSINESS WIRE)--Sep. 4, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Benjamin Wolin as chair of its board of directors effective September